Ms Ramsauer said that beyond the trial, regional efforts were underway to accelerate vaccine licensure and ensure equitable access.
WHO has unveiled a global Strategic Preparedness and Response Plan (SPRP) to tackle human-to-human transmission of mpox.
The Coalition for Epidemic Preparedness Innovations (CEPI) said it would invest up to $50 million over 10 years to help Senegal’s Institut Pasteur manufacture vaccines.
The federal government says it is engaging with the WHO and the CEPI to develop new therapeutics and a vaccine for Lassa fever.
“The meeting is of a single-item agenda, which will discuss the delivery of the COVID-19 vaccines.”
